Fresh analysis indicates that individuals who discontinue blockbuster GLP-1 drugs like semaglutide or tirzepatide tend to recover shed pounds far faster than those who stop conventional diet and exercise programs.
Published data in a leading health publication points out that while obese people can lose substantial amounts of their total mass while undergoing treatment, the mass is regained at an average rate of nearly a kilo each month upon discontinuation.
"Users using these drugs need to be cognizant of the risk of quick rebound weight gain when the therapy concludes," cautioned lead investigator Dr. Susan Jebb.
That rate of regain means a reversion to pre-treatment weight within about a year and a half.
Weighing Approaches
The analysis, which examined dozens of trials involving thousands of patients, contrasted the results of the injectable medications with conventional dieting.
The team emphasize that people who lose weight through diet and exercise typically see a slower creep back—around 100 grams monthly—post-intervention.
Understanding the Quick Regain
Experts suggest the way of the injections is key to understanding the amplified weight return.
The injections copy a natural hormone called glucagon-like peptide-1, which controls feelings of fullness.
"Artificially providing GLP-1 levels far above than the body's typical production might result in the system to generate a reduced amount of its own natural hormone, and may also diminish sensitivity to its effects," explained Dr. Adam Collins, a dietetics specialist.
"Withdrawal of this medication means hunger is unsuppressed, making binge eating much more probable."
An Ongoing Issue?
Medical guidelines recommend the jabs for individuals with weight-linked health risks, accompanied by prescribed lifestyle changes.
Professionals say that, given the likelihood of relapse, the treatment might need to be life-long.
This view is supported by drug manufacturers, who state that the results "emphasize the long-term nature of obesity," akin to managing diseases like diabetes.
Patient Experiences
People who have come off the medication report a powerful return of hunger.
"I experienced a trigger that goes on and I was suddenly ravenous," said an individual.
The struggle is compounded if patients have not established sustainable dietary or behavioural changes during treatment.
Significant Adoption
Figures suggest that a significant number of adults in the UK have used these injections in the last 12 months, with interest continuing to grow.
- Adoption is greater among women compared to men.
- The 40s and 50s age group shows the greatest usage rates.
- Many obtain the drugs through private prescriptions rather than public health services.
In conclusion, experts stress that while these medications are potent agents for shedding pounds, they are not a magic cure and long-term success likely depends on combined lifestyle support.
